Chronic airflow obstruction in Tanzania - a cross-sectional study by Zoller, Thomas et al.
RESEARCH ARTICLE Open Access
Chronic airflow obstruction in Tanzania – a
cross-sectional study
Thomas Zoller1,2,3,4,5, Elirehema H. Mfinanga2, Tresphory B. Zumba2, Peter J. Asilia2, Edwin M. Mutabazi2,
David Wimmersberger1,5, Florian Kurth3,4, Francis Mhimbira2, Frederick Haraka1,2,5 and Klaus Reither1,5,6*
Abstract
Background: Chronic obstructive pulmonary disease is a global problem and available data from sub-Saharan
Africa is very limited.
Methods: A cross-sectional facility-based pilot study among patients and visitors to an urban and a rural primary
healthcare facility was conducted in coastal Tanzania. The primary outcome was the prevalence of chronic airflow
obstruction.
Results: The final analysis included 598 participants with valid post-bronchodilator spirometry. Applying ATS/ERS
spirometric criteria, chronic airflow obstruction was found in n = 24 (4%, CI95 2.7–5.9) participants and in n = 30
(5%, CI95 3.5–7.1) applying GOLD spirometric criteria. To analyse risk factors for chronic airflow obstruction including
those not meeting ATS/ERS or GOLD criteria, FEF25–75 and FEV1% predicted was analysed in participants without
evidence of pulmonary restriction among those exposed or not exposed to risk factors (n = 552). FEV1% predicted,
but in particular FEF25–75 decreased with increasing symptom severity of shortness of breath as well as limitations in
daily activities of participants. Cooking in general and cooking with biomass fuels vs. gas or electricity was
associated with significantly lower FEF25–75, but not with lower FEV1% predicted. Participants having refrained from
taking a job because of shortness of breath exhibited lower FEF25–75 (p < 0.01). A history of prior active TB was the
most relevant risk factor associated with a decrease in FEF25–75 as well as FEV1% predicted.
Conclusion: This study demonstrated a relevant prevalence of chronic airflow obstruction in primary healthcare
attendants and healthy visitors of a Tanzanian hospital. Using the baseline data provided, larger and population-
based studies are needed to validate these findings. TB may have more impact on development of chronic airway
obstruction than smoking in Africa. Due to the influence of age on the GOLD definition of chronic airflow
obstruction, studies should report results using both ATS/ERS and GOLD definitions and include age-stratified
analysis. Analysis of FEV1 and in particular FEF25–75 may yield additional information on risk factors and earlier
stages of chronic airflow obstruction.
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Background
Chronic airflow obstruction (CAO), caused by a chronic
inflammation of airways in response to exposure to
dusts and fumes is a characteristic feature of chronic
obstructive pulmonary disease (COPD). CAO leads to a
decline in lung function and to subsequent loss of exer-
cise capacity. Cigarette smoking is the major causative
factor for CAO in industrialized countries [1], leading to
an overall population prevalence between 5% and 25% in
Europe, North America, Latin America and Asia [2–5].
COPD is a disease mainly affecting higher age groups
and most studies have so far addressed the population
above the age of 40 years. Little is known however on
prevalence and risk factors of COPD in developing
countries with younger populations, and particularly in
sub-Saharan Africa. Recently, the BOLD study investi-
gated prevalences of CAO on a global level and provided
data from Latin America and Asia as well as data from
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two study sites in Africa [2, 3, 6, 7]. Previous studies in
sub-Saharan Africa have mostly focussed on risk groups
with occupational exposure such as miners [8–11].
Epidemiology and risk factors of COPD in developing
countries likely differ from those in the developed world.
While cigarette smoking is less common in developing
countries, factors like prolonged exposure to biomass
fuels from cooking starting from early childhood, cook-
ing indoors in rooms shared for living and sleeping
purposes, high TB prevalence and different age structure
have relevant influence on COPD epidemiology [12]. At
present, it is unclear which effects this life-long exposure
to biomass fuels in Africa has for the development of
chronic obstructive pulmonary disease. Moreover, there
is little data on chronic obstructive pulmonary disease in
young African populations.
To gather data on CAO in Tanzania, we examined
patients attending primary healthcare facilities as well as
persons accompanying patients using a questionnaire
and performed pre- and post-bronchodilator spirometry.
Tanzanian Lung Health Study (TLHS) aims to provide
first estimates on CAO in Tanzania and to explore risk
factors as well as medical and social aspects of CAO,
providing baseline data for further studies on a larger
scale. Moreover, TLHS aims to give additional informa-
tion on analysis of spirometric outcomes other than the
standard definitions of CAO and their diagnostic value
to detect earlier stages of small airways disease in an
African setting.
Methods
A cross-sectional facility-based study was conducted
among attendants, accompanying persons and visitors to
the rural Bagamoyo District Hospital (Bagamoyo, Pwani,
Tanzania), and the urban Mwananyamala Regional Hos-
pital (Dar es Salaam, Tanzania) between October 2015
and September 2016. Both study centres are located in
coastal Tanzania without mining industry or exposure to
other region-specific lung hazards. The primary outcome
was spirometric evidence of CAO. Secondary outcomes
were risk factors and parameters indicating social
impact. Participants were eligible for inclusion if they
were at least 18 years of age and either attendants of a
primary healthcare clinic for any reason other than an
acute respiratory problem, persons accompanying
patients or visitors to the hospital visiting inpatients.
Participants visiting the hospital for other reasons, hav-
ing medical contraindications against bronchodilator
drugs or having any other physical or mental condition
limiting the ability to obtain a valid spirometry result
were excluded (hospitalisation within <3 months, newly
diagnosed heart disease within <3 months, uncontrolled
hypertension, resting heart rate > 100/min., uncontrolled
diabetes, pregnancy, acute infections or fever, acute pain,
smoking during the last 2 h, thoracic or abdominal
surgery within <3 months or any other severe physical
or mental disease limiting the ability to comply with in-
structions for spirometry). To allow analysis of outcomes
in patients across all relevant age groups, age-stratified
sampling was used. Within age-strata, participants were
invited randomly using a predefined selection procedure.
A sample size of 600 participants was intended to
provide an acceptable prevalence estimate with 2.5%
precision for this pilot study assuming a prevalence of
10% of chronic airflow obstruction.
After obtaining informed consent either in writing or
by an impartial witness, participants were interviewed by
a trained physician or a study nurse to obtain data on
lung health and TB history and trained in performing
spirometry supported by a video.
After spirometry was performed, patients inhaled 4
times 100 μg of salbutamol under supervision of a nurse
using a spacer. Spirometry was repeated after 15 min.
Quality criteria for spirometry were applied according to
the 2005 ATS/ERS guidelines [13]. Spirometer readings
were checked for acceptability and repeatability criteria
by the physician performing the test and checked again
by a senior pulmonologist. Only spirometer readings
meeting all acceptability as well as repeatability criteria
(minimum grade A and B) were finally accepted. Spir-
ometry was performed using the NDD EasyONE World
Spirometer (Zürich, Switzerland). Spirometric prediction
equations of the Global Lung Function Initiative for
African Americans were used [14].
Spirometric data was analysed for prevalence of CAO
applying the FEV1/FVC < 5th percentile predicted (LLN)
method (ATS/ERS spirometric criteria) as well as the
GOLD definition with a fixed FEV1/FVC ratio < 0.7. A
positive bronchodilator response was defined as an in-
crease of FEV1 and/or FVC >12% and at least 200 ml
compared to baseline. To further assess airflow obstruc-
tion including earlier stages, the post-bronchodilator
forced expiratory flow at 25–75% of forced vital capacity
(FEF25–75) [15] and the FEV1% predicted were used. As
pulmonary restriction influences FEF25–75 and FEV1%
predicted, participants with evidence of restriction (FVC
< 5th percentile of FVC predicted and FEV1/FVC >0.85,
as defined by ATS/ERS criteria [16]) were excluded from
this analysis.
Data was analysed using JMP ver. 14. Median FEF25–75
and FEV1% predicted values were compared among par-
ticipants exposed vs. unexposed to risk factors for CAO.
Parameters were compared between risk groups using
the Mann-Whitney-U-test to compare two and the
Kruskal-Wallis-Test to compare multiple groups. Χ2 test
was used to compare categorical outcomes between
groups. Differences were considered significant when
p was <0.05.
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Results
Study population
A total of 1224 participants either attending or visiting
the two health facilities of the study gave informed
consent. 195 participants were excluded due to violat-
ing exclusion criteria and 32 participants due to
incomplete datasets. 399 patients did not produce a
post-bronchodilator spirometry meeting ATS/ERS quality
criteria despite intensive video-assisted training and were
excluded. The study population included 598 participants
with valid post-bronchodilator spirometry.
We analysed if the population of participants not able
to produce a spirometry according to ATS/ERS quality
criteria was different from the study population in the
final analysis. Slightly more women were excluded based
on this criterion (54.6% vs. 45.3%, p = 0.05), but there
was no significant difference in terms of age (median
46 vs. 45 years, p = 0.23), history of active TB infec-
tion (p = 0.93), visitors vs. patients (p = 0.4), education
(p = 0.46), reason for seeking medical attention among
patients (p = 0.71) and smoking status (p = 0.07).
Demographic and social characteristics
The median age of the study population was 46 years
(IQR 37–57 years) across the different age groups in-
vited for participation, and 72% of patients were at least
40 years old (for details see Table 1). There was an equal
gender distribution. The majority of participants (60%)
were visitors to the hospital or persons accompanying
patients to primary healthcare clinics. The level of edu-
cation was generally low, with most participants having
either no (29%) or only primary school (48%) education.
Main occupations were business and trade (29%) as well
as farming and agriculture (24%). The leading reasons
for seeking medical attention for patients attending pri-
mary healthcare clinics were infections/fevers (17%),
musculosceletal problems and injuries (15%) and cardio-
vascular problems (14%). The majority of participants
cooked with charcoal (60%) and wood (25%), and only
few participants with gas (8%).
CAO prevalence and bronchodilator response
Applying ATS/ERS criteria, CAO was found in n = 24
(4.0%, CI95 2.7–5.9) participants and n = 30 (5.0%, CI95
3.5–7.1) met GOLD spirometric criteria for CAO. There
was an obvious difference in CAO prevalence across age
groups using the two definitions. Applying ATS/ERS cri-
teria, prevalence of CAO increased only moderately with
age from 3.6% to 5.6% in 4 age groups, whereas preva-
lence defined by GOLD spirometric criteria was only
1.8% in participants <40 years of age, but 11.3% in
participants >60 years of age (for details see Table 2).
Overall, n = 46 (7.7%, CI95 5.8–10.1) showed a positive
bronchodilator response. Most participants meeting
either ATS/ERS or GOLD spirometric criteria had either
mild or moderate levels of obstruction (see Table 3).
Correlation of symptoms and limitations of daily activities
with spirometry
Current definitions of CAO only allow to define pres-
ence or absence of obstruction and may not capture
Table 1 Demographic and social characteristics of the study
population
N % of study
population
Age group 18–39 169 28
40–59 299 50
60–79 124 21
> = 80 6 1
Gender Male 310 52
Female 288 48
Type of participant Patient of hospital 242 40
Visitor to hospital 356 60
Education No formal education 173 29
Primary school 289 48
Secondary school 99 17
University/college 31 1
Occupationa Business and trade 172 29
Farming and
agriculture
141 24
Craftsmen 38 6
Drivers 21 4
Reasons for seeking medical
attention (patients)a
Infections/fevers 41 17
Musculosceletal
problems
35 15
Cardiovascular
problems
33 14
Gastrointestinal
problems
29 12
Non-acute respiratory
problems
25 10
Urogenital/
reproductive
problems
13 5
Cooking fuel Charcoal 360 60
Wood in open stove 137 23
Wood in open fire 12 2
Gas 49 8
Smoking status Never smoker 435 73
Current or recent
smoker
87 15
Ex-smoker
(≥6 months
abstinence)
76 13
aOnly major categories shown
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more subtle changes in airflow obstruction; we analysed
therefore FEF25–75 as well as FEV1% predicted values in
participants without evidence of restriction (n = 552) in
an exploratory analysis and correlated spirometric values
with symptoms and limitations in daily life, and with
parameters causing social impact. Participants graded
the level of respiratory symptoms (shortness of breath,
coughing) and social impact (limitation of daily activities
or at work, limitation of activities at home) on a scale
between 0 (no symptoms) and 3 (severe/frequent symp-
toms), and for coughing up to 4 (constant symptoms).
The results are shown in Fig. 1. Symptom severity in-
creased and indicators for social impact deteriorated
with decreasing FEF25–75 and FEV1% predicted.
Risk factors for airflow obstruction
To identify risk factors promoting airflow obstruction,
data from the patient interview was used to classify
patients into exposed and non-exposed groups and
FEF25–75 as well as FEV1% predicted values in patients
without restriction were compared. The results are given
in Table 4. There was no significant difference in lung
function parameters between participants who smoked
or were exposed to dusts and fumes at their workplace.
Cooking in general and cooking with biomass fuels vs.
gas or electricity was associated with significantly lower
FEF25–75, but not with lower FEV1% predicted. The
biggest and significant differences in both lung function
parameters were observed between participants with a
history of TB vs. those who reported no history of prior
TB (p < 0.01). Symptoms of chronic bronchitis were as-
sociated with a decrease in both lung function parame-
ters (p = 0.02). Participants having refrained from taking
a job because of shortness of breath exhibited lower
FEF25–75 and FEV1% predicted values, but the difference
was only significant for FEF25–75.
Discussion
Chronic airflow obstruction is an important cause of
morbidity and mortality, and has major impact on the
lives of those affected. Data from this pilot study in
coastal Tanzania indicate a relevant level of CAO among
urban and rural inhabitants. CAO can be found across
all age groups and those affected may suffer from limita-
tions in their ability to work and in quality of life.
This study showed that approximately one out of twenty
inhabitants of coastal Tanzania has CAO according to
both definitions currently used. Whereas the ATS/ERS
definition using the LLN method showed only a moderate
increase of prevalence with age, the GOLD definition
showed a six-fold higher prevalence of CAO in the highest
vs. the youngest age group. As the GOLD definition uses
a fixed FEV1/FVC ratio of 0.7 as cut-off to define CAO,
older age groups are overrepresented as the FEV1/FVC ra-
tio declines physiologically with increasing age [17]. There
is a persisting controversy on which classification to use;
the LLN method indicating CAO is better suited for
research purposes as it controls for ageing of the lung
whereas the GOLD spirometric criteria are preferred by
many clinicians due to their simplicity. The results from
this study however underscore the concerns regarding
over-diagnosis of elderly patients using the GOLD defin-
ition as well as potential under-diagnosis in younger pa-
tients, and demonstrate this effect in an African setting.
Future epidemiological studies in Africa should therefore
report results using both definitions until a universally
accepted method has been developed. Moreover, results
should include prevalences stratified by age groups, as
exposure to biomass fuel smoke starting from birth or
Table 2 Prevalence of chronic airflow obstruction in the study
population according to spirometric criteria of ATS/ERS using
FEV1/FVC < 5th percentile predicted (LLN) method or the Global
Initiative for Chronic Obstructive Lung Disease (GOLD) criteria
Risk factor Group n Meet criteria % CI95
CAO (LLN) All 598 24 4.0 2.7–5.9
Age groups
18–39 169 6 3.6 1.6–7.5
40–59 299 11 3.7 2.0–6.5
60–79 124 7 5.6 2.8–11.2
> = 80 6 0 0
CAO (GOLD) All 598 30 5.0 3.5–7.1
Age groups
18–39 169 3 1.8 0.6–5
40–59 299 13 4.3 2.5–7.3
60–79 124 14 11.3 6.8–18
> = 80 6 0 0
Table 3 Severity of CAO according to spirometric criteria of
ATS/ERS using FEV1/FVC < 5th percentile predicted (LLN)
method or the Global Initiative for Chronic Obstructive
Pulmonary Disease (GOLD) criteria
n % FEV1% of predicted
CAO (LLN) All 24
Very severe 2 8.3 <35%
Severe 0 0 35–49%
Moderately severe 3 12.5 50–59%
Moderate 6 25.0 60–69%
Mild 13 54.2 ≥70%
CAO (GOLD) All 30
Very severe 2 6.7 <30
Severe 0 0 30–49
Moderate 15 50.0 50–79
Mild 13 43.3 ≥ 80
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even in utero [12] may lead to an earlier onset and higher
prevalence of CAO in young African populations.
Few studies have reported prevalence of CAO in
general populations from sub-Saharan Africa not
exposed to special risk factors (e.g. gold miners). The
reports available so far do not give consistent results
across African regions; the prevalences found in this
study were lower than in a recent study from Nigeria
(5.1%–10% (LLN)) [6], Malawi (14% (GOLD)) [18] or
from Uganda (12.4% (LLN), 16.2% (GOLD)) [19], but
higher than in Cameroon (2.4% (LLN), 0.5% (GOLD))
[20]. Consistent across all studies, the majority of
patients had either mild or moderate severity of obstruc-
tion. There is still no sufficient data from large
population-level spirometry-based and quality-assured
studies in sub-Saharan Africa to give a good CAO preva-
lence estimate in general or specific to African regions;
the data presented in this study add relevant baseline
data for planning studies on a larger scale and under-
score the importance of reporting data in different age
groups.
Risk factors for CAO likely differ from other regions
of the world due to different living circumstances, living
standards and lifestyle of populations. Smoking [1] and
exposure to particulate matter [21] in the air are the
predominant risk factors for CAO in industrialized
countries. Data from China, Latin America and Turkey
show a moderately increased risk of CAO after exposure
to smoke from biomass fuels, with a stronger effect for
firewood than for charcoal [22]. Following these principles,
indoor air pollution is generally assumed to be a major risk
factor in Sub-Saharan Africa [23]. Four recent studies
however did not demonstrate a clear association between
indoor use of biomass fuel with CAO [6, 7, 19, 20].
Chronic airflow obstruction may begin early in life and
investigation of first signs may be missed by applying the
ATS/ERS or GOLD criteria only – the predominant
method of analysis used in studies from Africa. Large
population based epidemiological studies have however
demonstrated excellent sensitivity for early detection of
airway pathology using continuous analysis of FEV1 and in
particular FEF25–75 [21, 24, 25] as well as FEV1 as a
percentage of FVC [21]. In an exploratory approach, we
therefore used FEF25–75 as well as FEV1% predicted to
detect more subtle changes in airway pathology. Analysis
of FEF25–75 seemed to have a higher sensitivity and better
correlation with severity of symptoms and physical limita-
tions than FEV1% predicted. Both parameters indicated
Fig. 1 Chronic airflow obstruction in relation to severity of symptoms: post-bronchodilator median FEF25–75 (l/s.) and FEV1 in patients without
restriction by symptom severity (0 no symptoms, 3 severe symptoms). Boxplot shows median & interquartile ranges and whiskers denote the
furthest point within 1.5× interquartile range. Number of subjects in severity groups (from 0 to 3): shortness of breath n = 331, 140, 67, 13;
coughing n = 447, 75, 20, 9; limitation of daily activities or at work n = 409, 84, 43, 15; limitation of activities at home n = 418, 81, 38, 14, respectively.
Note: the symptom “coughing” was assessed in 4 severity grades. Only one participant graded coughing with severity 4; this participant and was
removed from the figure, as no boxplot could be drawn from a single value. The patient had a FEF25–75 of 1.99 l/s and a FEV1/PRED of 76.39%
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differences among participants exposed and unexposed to
risk factors for CAO typical for an African setting and in-
dicated their potential significance for causing social im-
pact. We therefore recommend that in larger studies on
CAO in Africa, results should be reported both using the
standard CAO definitions, but also using analysis of con-
tinuous spirometric values such as FEF25–75 and FEV1%
predicted.
Recent meta-analyses and studies on a global scale
were able to demonstrate that active tuberculosis as an
infection causing chronic pulmonary inflammation over
a prolonged period of time is a major factor contributing
to CAO [26–28]. In this study, a history of active TB in-
fection was the most relevant risk factor associated with
a lower FEF25–75 as well as a lower FEV1% predicted.
The observed effect of TB infection is consistent with
other recently published studies from local African pop-
ulations [6, 18, 29] and underscores the significance of
TB for development of chronic lung disease in Africa.
This study had limitations. In order to examine CAO
in a sufficient number of subjects in each age class in
this study, age-stratified sampling was used. The popula-
tion sample examined consisted of a mixed population
composed of hospital visitors and patients. Therefore,
particularly the prevalence of CAO should not necessar-
ily be regarded as representative for the general popula-
tion. An unexpectedly high number of study participants
was unable to produce a spirometry meeting ATS/ERS
quality criteria despite intensive and standardized pre-
spirometry training including a training video two times.
In previous studies in developing country settings in
Latin America and Africa [6, 19, 30], observed spirom-
etry failure rates were lower except for one study from
Malawi with a similar rate of exclusions [7]. Local
cultural and religious factors in this community causing
people not to expose themselves in a medical examin-
ation requiring their participation with maximum mus-
cular force used, together with a generally low level of
education probably have contributed to this high failure
rate. Main findings in this study, particularly with regard
to risk factors for CAO need to be confirmed in larger
population-based studies.
Conclusions
In conclusion, this study demonstrated a relevant burden
of CAO in a Tanzanian population and showed major
differences in prevalence as well as age-specific preva-
lence between the two standard definitions of CAO
used. Although most individuals with evidence of CAO
had only mild or moderate obstruction, CAO likely has
relevant social and social and economic impact for those
affected. TB may have more impact on development of
chronic airway obstruction than smoking in Africa.
Analysis of FEV1 and FEF25–75 in epidemiologic studies
on CAO may give important information on risk factors
and impact in addition to using standard definitions for
CAO alone.
Table 4 Post-bronchodilator FEF25–75 (l/s.) and FEV1% predicted in participants without restriction, with risk factors, symptoms and
limitations caused by chronic airflow obstruction in participants without evidence of restriction)
Exposure N %
of n
Median FEF25–75 (IQR),
post bronchodilator (L/s.)
Δ FEF25–75
(L/s.)
p Median FEV1%
PRED (IQR)
Δ FEV1%
PRED
p
Smoking Current or former
smoker
155 28.1 3.1 (2.15–3.76) 0.2 0.4 96.44 (87.39–104.12) 1.23 0.59
Never smoker 397 71.9 2.9 (2.05–3.65) 95.21 (86.14–106.34)
Exposure to dusts and
fumes at workplace
Exposure 442 80.1 2.97 (2.03–3.7) 0.19 0.78 95.15 (85.94–104.42) 3.74 0.07
No exposure 110 19.9 2.78 (2.2–3.63) 98.88 (89.31–107.82)
Cooking Regular cooking 317 57.4 2.74 (1.93–3.47) 0.43 <0.01 95.19 (85.61–105.79) 0.2 0.12
No regular cooking 231 41.8 3.16 (2.34–3.99) 95.39 (88.62–105.37)
Biomass fuels for cooking Cooking with
wood or coal
472 85.5 2.84 (1.96–3.61) 0.53 <0.01 95.15 (85.62–104.93) 1.33 0.39
Cooking with gas
or electricity
47 8.5 3.36 (2.5–3.99) 96.47 (72.93–106.29)
History of active TB History of active TB 71 12.9 2.07 (1.5–3.12) 0.95 <0.01 96.2 (87.48–106.34) 6.34 <0.01
No history of active TB 481 87.1 3.02 (2.23–3.71) 89.86 (77.11–101.86)
Chronic bronchitis
(chronic cough and sputum)
Yes 46 8.3 2.41 (1.44–3.49) 0.58 0.02 90.73 (74.02–103.34) 4.86 0.02
No 506 91.7 2.99 (2.1–3.67) 95.6 (86.89–105.86)
Having ever refrained
from taking a job because
of shortness of breath
Yes 87 15.8 2.43 (1.56–3.28) 0.6 <0.01 95.25 (81.58–103.25) 0.28 0.14
No 465 84.2 3.02 (2.17–3.71) 95.53 (86.99–105.96)
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